CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: This reinforces the central role of STAT5 in the maintenance of chronic myeloid leukemia [37, 21], in accordance with the known effects of this transcription factor on cell cycle, apoptosis, production of ROS and the sensitivity of CD34+ cells to TKI [37].